Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2023 (6)
  • 2022 (12)
  • 2021 (15)
  • 2003 (1)

Subject

  • Drug Trafficking (204)
  • Seizures (Drugs/Property) (176)
  • Synthetic drugs (166)
  • Task Forces/Task Force Officers (161)
  • Major Law Enforcement Operation (122)
  • Guns/Weapons (91)
  • OCDETF/Task Force (80)
  • Overdose (65)
  • Arrests/Convictions - Major (58)
  • Gangs (47)
  • Fake Pills (46)
  • Prescription Drugs (42)
  • Narcoterrorism (36)
  • Diversion Division (31)
  • Guilty Plea (31)
  • Outreach/Drug Prevention (24)
  • Press Conferences (20)
  • Money Laundering (17)
  • One Pill Can Kill (10)
  • HIDTA (9)
  • Public and Media Affairs - also see Congressional Affairs (8)
  • Take Back Day (8)
  • Dark Web- Internet Trafficking (7)
  • Fentanyl Awareness (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • International/Foreign Operations (6)
  • Asset Forfeiture (5)
  • Extraditions (3)
  • Intergovernmental Affairs (2)
  • Museum and Visitors Center (2)
  • Intelligence Division - Intelligence Products (1)
  • Pharmaceuticals/Pharmacists/Physicians (34)
  • Congressional Affairs (0)

Drug Name

  • Opioids (25)
  • Oxycodone (11)
  • Synthetic Opioids (10)
  • Fentanyl (6)
  • Hydromorphone (6)
  • Benzodiazepines (3)
  • Morphine (3)
  • Steroids (3)
  • Cocaine (1)
  • Heroin (1)
  • Methadone (1)
  • Methamphetamine (1)

Field Division

  • St. Louis (32)
  • Sede (21)
  • New York (20)
  • Chicago (19)
  • Miami (16)
  • Atlanta (11)
  • New Jersey (11)
  • Dallas (8)
  • El Paso (8)
  • Houston (8)
  • San Francisco (6)
  • Seattle (6)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • Louisville (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Philadelphia (1)
  • Phoenix (1)
  • Washington, DC (34)
Clear All Results
PRESS RELEASE

DEA Washington Division is Ready to Celebrate the 25th National Drug Take Back Day Across the DMV

Octubre 16, 2023
Washington, DC – The Drug Enforcement Administration (DEA) will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. in more than 300 collection sites across Maryland, District of Columbia, and Virginia (DMV). Through a collaborative effort with local law enforcement...
Octubre 16, 2023
PRESS RELEASE

Former Chief Operating Officer of Area Pain Clinics Indicted

Septiembre 29, 2023
CHARLOTTESVLLE, Va. – A federal grand jury returned an indictment this week charging the former chief operating officer of area pain clinics with three conspiracy counts for her alleged involvement in health care fraud and illegal drug distribution. Jennifer Ann “Jen” Adams, 50, of Mount Pleasant, South Carolina, is charged...
Septiembre 29, 2023
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Julio 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
Julio 06, 2023
PRESS RELEASE

The United States and Montgomery County Based Pharmacy and Pharmacist Reach a Consent Decree Over Allegations of Illegally Dispensed Controlled Substances

Mayo 31, 2023
Greenbelt, Maryland - U.S. District Judge Peter J. Messitte approved the United States’ consent decree with Abtin Youssefi-Rashti, a Montgomery County based pharmacist, and Upton Care Pharmacy, Inc. (“Upton Care”), resolving the United States’ civil allegations that Youssefi-Rashti and Upton Care violated the Controlled Substances Act (“CSA”) in illegally dispensing...
Mayo 31, 2023
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

Enero 24, 2023
Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
Enero 24, 2023
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

Enero 24, 2023
Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
Enero 24, 2023
PRESS RELEASE

Amherst County Veterinarian Sentenced for Opioid Theft

Junio 22, 2022
LYNCHBURG, Va. – A former veterinarian, who admitted to stealing opioids, was sentenced today to eight months in federal prison. Patrick Gries, 54, of Madison Heights, Virginia, pleaded guilty in January 2022 to one count of adulteration of a drug held for sale after shipment in interstate commerce and one...
Junio 22, 2022
PRESS RELEASE

Newport News Pharmacy Agrees to Pay Civil Penalty under the Controlled Substances Act

Junio 21, 2022
NORFOLK, Va. – Hidenwood Pharmacy, Inc., located in Newport News, and its owner, Anne Hutchens, of Seaport, have agreed to pay $125,000 to settle civil penalty claims stemming from alleged record-keeping violations associated with controlled substances. The government alleged that the Hidenwood Pharmacy failed to comply with various recordkeeping requirements...
Junio 21, 2022
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

Junio 16, 2022
Baltimore, Maryland – Norman Rosen, age 84, of Towson, Maryland, pleaded guilty today to conspiracy to distribute and dispense oxycodone in connection with his operation of Rosen-Hoffberg Rehabilitation and Pain Management Associates, P.A., where he was Medical Director and part-owner. The guilty plea was announced by Jarod Forget, Special Agent...
Junio 16, 2022
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

Junio 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
Junio 08, 2022
Showing 1 - 10 of 34 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español